Minerva Neurosciences Inc Cash Flow Reinvestment Rate

Latest as of September 2017: 3.21x

Minerva Neurosciences Inc cash flow reinvestment rate. Minerva Neurosciences Inc (NERV) has a Cash Flow Reinvestment Rate of 3.21x as of September 2017, reinvesting $79.80 Million (capex $0.00 plus investments $-79.80 Million) from operating cash flow of $24.89 Million. Explore Minerva Neurosciences Inc debt service capacity to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

3.21x

(Capex + Investments) / Operating CF

Total Reinvested

$79.80 Million

Capex + Investments

Operating Cash Flow

$24.89 Million

USD

Capital Expenditures

$0.00

USD

Cash Flow Reinvestment Rate of Minerva Neurosciences Inc (2017–2017)

Cash flow reinvestment rate of Minerva Neurosciences Inc from 2017 to 2017. Historical reinvestment intensity for Minerva Neurosciences Inc across 1 annual periods. Explore Minerva Neurosciences Inc capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.

Minerva Neurosciences Inc Cash Flow Reinvestment Rate by Year (2017–2017)

Minerva Neurosciences Inc cash flow reinvestment rate by year from 2017 to 2017. Year-by-year capital reinvestment analysis for Minerva Neurosciences Inc. For the full cash flow conversion analysis, see how efficiently does Minerva Neurosciences Inc generate cash.

Year	Reinvestment Rate	Total Reinvested (USD)	Operating CF	Capex	YoY Change
2017	34.66x	$107.19 Million	$3.09 Million	$52.40K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow